Bio-Techne Corp.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2017 | $625.5M | $1.53B | $59.8M |
| Jun 2017 | $608.6M | $1.56B | $91.6M |
| Sep 2017 | $567.3M | $1.53B | $72.5M |
| Dec 2017 | $557.6M | $1.56B | $121.5M |
| Mar 2018 | $559.5M | $1.62B | $86.6M |
| Jun 2018 | $514.1M | $1.59B | $122.0M |
| Sep 2018 | $762.7M | $1.87B | $94.7M |
| Dec 2018 | $748.4M | $1.84B | $85.9M |
| Mar 2019 | $726.4M | $1.87B | $95.6M |
| Jun 2019 | $718.8M | $1.88B | $100.9M |
| Sep 2019 | $750.8M | $1.93B | $99.9M |
| Dec 2019 | $675.1M | $2.00B | $110.3M |
| Mar 2020 | $707.8M | $2.00B | $156.2M |
| Jun 2020 | $646.4M | $2.03B | $146.6M |
| Sep 2020 | $613.8M | $2.05B | $169.4M |
| Dec 2020 | $546.0M | $2.07B | $165.5M |
| Mar 2021 | $545.2M | $2.08B | $186.1M |
| Jun 2021 | $700.0M | $2.26B | $199.1M |
| Sep 2021 | $630.8M | $2.27B | $196.3M |
| Dec 2021 | $601.9M | $2.30B | $211.8M |
| Mar 2022 | $585.5M | $2.30B | $160.8M |
| Jun 2022 | $593.0M | $2.29B | $172.6M |
| Sep 2022 | $599.6M | $2.35B | $165.3M |
| Dec 2022 | $536.3M | $2.36B | $164.7M |
| Mar 2023 | $710.0M | $2.60B | $127.3M |
| Jun 2023 | $672.2M | $2.64B | $180.6M |
| Sep 2023 | $757.6M | $2.76B | $148.7M |
| Dec 2023 | $767.2M | $2.73B | $130.1M |
| Mar 2024 | $706.8M | $2.72B | $139.9M |
| Jun 2024 | $635.0M | $2.70B | $151.8M |
| Sep 2024 | $597.4M | $2.74B | $187.5M |
| Dec 2024 | $591.9M | $2.67B | $177.5M |
| Mar 2025 | $626.2M | $2.64B | $140.7M |
| Jun 2025 | $639.1M | $2.56B | $162.2M |
| Sep 2025 | $560.3M | $2.53B | $145.0M |
| Dec 2025 | $511.7M | $2.52B | $172.9M |
| Mar 2026 | $465.3M | $2.55B | $209.8M |
| Jun 2026 | $478.5M | $2.59B | $264.7M |